Namisha Thapa
Gastroenterology · Temple, TXNPI 1447784897
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 66.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $2,465 and has fallen 88.2% since, to $292 in 2025. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 68 payments — averaging $55.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- AbbVie$476
- Sanofi$120
- E.r. Squibb & Sons, L.L.C.$109
- Phathom Pharmaceuticals, Inc.$84
- Aimmune Therapeutics, Inc.$77
- plus $417 from 13 others
What the payments were for
- Travel & lodging$1,53740%
- Food & beverage$2,13556%
- Education$1354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $2,524 |
| AbbVie | 17 | $476 |
| Sanofi | 4 | $120 |
| E.r. Squibb & Sons, L.L.C. | 1 | $109 |
| Phathom Pharmaceuticals, Inc. | 4 | $84 |
| Aimmune Therapeutics, Inc. | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Ironwood Pharmaceuticals, Inc | 2 | $52 |
| Medtronic | 2 | $39 |
| Braintree Laboratories, Inc. | 2 | $37 |
| Pfizer | 2 | $37 |
| Laborie Medical Technologies Corp. | 1 | $36 |
| Gilead | 1 | $33 |
| Ardelyx, Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $24 |
| Exact Sciences | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,003
- ACQUIRE$602
- EXALT Model D$238
- ORISE$137
- Rinvoq$103
- Skyrizi$102
How this compares
$3,808 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 111 | $7,174 |
| Pantoprazole Sodium | 29 | $624 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $189 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Temple
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
- Brooks CashHouston$867K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.